Literature DB >> 29710230

Long-term Outcomes of Temporal Hollowing Augmentation by Targeted Volume Restoration of Fat Compartments in Chinese Adults.

Ru-Lin Huang1, Yun Xie1, Wenjin Wang1, Pohching Tan1, Qingfeng Li1.   

Abstract

IMPORTANCE: Previous anatomical and clinical studies have suggested that targeted restoration of the volume and distribution of fat compartments using appropriate cannula entry sites and injection planes is an excellent fat-grafting technique for facial contouring and hand rejuvenation.
OBJECTIVE: To perform subjective and objective evaluations of the safe and effective profile of the targeted fat-grafting technique for temporal hollowing augmentation. DESIGN, SETTING, AND PARTICIPATIONS: In a retrospective cohort study, a total of 96 consecutive patients with temporal hollowing were treated at the Department of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, Shanghai, China, with the targeted fat-grafting technique from January 1, 2009, to January 1, 2017. MAIN OUTCOMES AND MEASURES: The safety and efficacy profile of this technique was evaluated by the following methods: (1) a quantitative measurement of fat-graft survival and temporal augmentation rates by using 3-dimensional laser scanning, (2) a subjective assessment using a satisfaction survey and the Hollowness Severity Rating Scale (grades range from 0-3, with higher grades representing more hollowness), and (3) the complication rate.
RESULTS: Of the 96 study patients, 94 (97.9%) were women and the mean (SD) age was 34.4 (7.4) years. Of the 142 autologous fat-grafting procedures performed, the mean (SD) total follow-up time was 16.3 (3.2) months, with a mean (SD) of 1.5 (0.7) procedures performed. The mean (SD) baseline volume requirement per temple for each patient was 12.8 (4.8) mL, and the total volume of the fat graft per temple was 17.8 (7.5) mL. Quantitative analysis revealed that the mean (SD) total augmentation volume per temple was 11.7 (3.0) mL, the total survival rate of the fat grafts was 65.7% (12.6%), and total augmentation rate of hollowness was 91.4% (23.4%). Subjective analysis revealed that all patients showed an improved appearance after fat grafting, and 142 temples (74.0%) exhibited clinical improvement by more than 2 grades. In all, 88 patients (91.7%) were satisfied with the outcomes, with a low complication rate reported. CONCLUSIONS AND RELEVANCE: The targeted fat-grafting technique allows the transplant of fat tissue into 4 separate fat compartments in a double-plane manner through a unique cannula entry site that avoids severe neurovascular injury. The long-term results demonstrate that this technique is an effective, reproducible, and safe approach for temporal hollowing augmentation. LEVEL OF EVIDENCE: 4.

Entities:  

Mesh:

Year:  2018        PMID: 29710230      PMCID: PMC6233616          DOI: 10.1001/jamafacial.2018.0165

Source DB:  PubMed          Journal:  JAMA Facial Plast Surg        ISSN: 2168-6076            Impact factor:   4.611


  28 in total

Review 1.  Anatomical Basis for Safe and Effective Volumization of the Temple.

Authors:  Andrew D Breithaupt; Derek H Jones; Andre Braz; Rhoda Narins; Susan Weinkle
Journal:  Dermatol Surg       Date:  2015-12       Impact factor: 3.398

2.  The utility of the high-resolution ultrasound technique in the evaluation of autologous adipose tissue lipofilling, used for the correction of post-surgical, post-traumatic and post-burn scars.

Authors:  Maria Scotto di Santolo; Marco Sagnelli; Giovanni Tortora; Maria Angela Santoro; Pier Luigi Canta; Guido Molea; Fabrizio Schonauer; Massimo Imbriaco
Journal:  Radiol Med       Date:  2016-02-04       Impact factor: 3.469

3.  The anatomy of temporal hollowing: the superficial temporal fat pad.

Authors:  Sharon Kim; Damir B Matic
Journal:  J Craniofac Surg       Date:  2005-07       Impact factor: 1.046

4.  Retinal and choroidal vascular occlusion after fat injection into the temple area.

Authors:  Linna Lu; Xiaofang Xu; Zhiliang Wang; Fuxiang Ye; Xianqun Fan
Journal:  Circulation       Date:  2013-10-15       Impact factor: 29.690

5.  Cell-assisted lipotransfer for facial lipoatrophy: efficacy of clinical use of adipose-derived stem cells.

Authors:  Kotaro Yoshimura; Katsujiro Sato; Noriyuki Aoi; Masakazu Kurita; Keita Inoue; Hirotaka Suga; Hitomi Eto; Harunosuke Kato; Toshitsugu Hirohi; Kiyonori Harii
Journal:  Dermatol Surg       Date:  2008-05-29       Impact factor: 3.398

Review 6.  Fat grafting in facial rejuvenation.

Authors:  Timothy J Marten; Dino Elyassnia
Journal:  Clin Plast Surg       Date:  2015-04       Impact factor: 2.017

7.  Middle temporal vein: a fatal hazard in injection cosmetic surgery for temple augmentation.

Authors:  Xuan Jiang; Da-lie Liu; Bing Chen
Journal:  JAMA Facial Plast Surg       Date:  2014 May-Jun       Impact factor: 4.611

8.  Facial augmentation with structural fat grafting.

Authors:  Sydney R Coleman
Journal:  Clin Plast Surg       Date:  2006-10       Impact factor: 2.017

9.  Facial Contouring by Targeted Restoration of Facial Fat Compartment Volume: The Midface.

Authors:  Wenjin Wang; Yun Xie; Ru-Lin Huang; Jia Zhou; Herrler Tanja; Peijuan Zhao; Chen Cheng; Sizheng Zhou; Lee L Q Pu; Qingfeng Li
Journal:  Plast Reconstr Surg       Date:  2017-03       Impact factor: 4.730

10.  Long-Term Outcome of Microautologous Fat Transplantation to Correct Temporal Depression.

Authors:  Su-Shin Lee; Yu-Hao Huang; Tsung-Yin Lin; Chih-Kang Chou; Hidenobu Takahashi; Chung-Sheng Lai; Sin-Daw Lin; Tsai-Ming Lin
Journal:  J Craniofac Surg       Date:  2017-05       Impact factor: 1.046

View more
  2 in total

1.  Contouring and augmentation of the temple using stromal vascular fraction gel grafting.

Authors:  Yuchen Zhang; Jialiang Zou; Yi Yuan; Jianhua Gao; Xihang Chen
Journal:  Front Surg       Date:  2022-08-16

Review 2.  Volume Retention After Facial Fat Grafting and Relevant Factors: A Systematic Review and Meta-analysis.

Authors:  Qianwen Lv; Xin Li; Yue Qi; Yunpeng Gu; Zhenjun Liu; Gui-E Ma
Journal:  Aesthetic Plast Surg       Date:  2020-01-15       Impact factor: 2.326

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.